UTEGCIL^TM

Tegafur 100mg and Uracil 224mg capsules

Sayre Therapeutics offers clinicians a convenient and effective oral formulation of Tegafur ( pro-drug of 5-FU) with Uracil for the management of metastatic colorectal cancer.

• Indication: TEGAFUR 100mg + URACIL 224mg capsules is indicated for the first line treatment of metastatic colorectal cancer with calcium folinate.
• Formulation: TEGAFUR 100mg + URACIL 224mg capsules are supplied as 1× 10’s Blister pack.
• Utegcil^® is:
  • Has comparable clinical efficacy to bolus 5-FU/LV in patients with metastatic colorectal cancer.
  • When administered with Leucovorin, provides better safety profile compared with 5-FU/LV.
  • More than 80% of patients preferred oral Tegafur/Uracil to I.V. bolus 5-FU.